Famous “Rocky” Actor Dolph Lundgren, 65, Says New Finance Is An “Angel” Despite “Severe” Age Gap- Joy of New Love During Cancer Fight

Lundgren’s Cancer Journey

Lundgren’s cancer journey began in 2015 when doctors found a tumor in his kidney, according to People magazine. The doctors were able to remove the cancerous tumor, but six more tumors were discovered at the time, one of which had grown too large to remove, so he had to start therapy with drugs.

In an interview with The LA Times, Lundgren said more tumors were discovered in the fall of 2021 when he arrived in London to film movie sequels to his "Aquaman" and "The Expendables" franchises. Lundgren eventually got a second opinion from a doctor who discovered that his kidney cancer was mutating more like lung cancer. The doctor overhauled the actor's treatment to approach it as if his cancer was lung cancer.

Genetic Testing For Mutations Create A New Treatment Option

Lundgren’s treatment is a result of the discovery of a genetic mutation in one of his tumors. This mutation, (we don’t exactly which genetic alteration, but Lundgren says it is commonly found in lung cancer) and it apparently opened up new possibilities for targeted therapies, which have dramatically increased survival rates for some people with lung cancer who have mutations for which drugs have been specifically developed.

Lundgren says his response to the medication has been remarkable, with his tumors shrinking significantly. As of now, the cancer has reduced by 90%, and Lundgren is undergoing the removal of scar tissue from the tumors.

What's targeted or Immuno-therapy?
Targeted therapy is a type of treatment that works by identifying specific markers on tumor cells. These markers allow doctors to target specific cancers with drugs or other treatments designed to attack them. By doing so, they can reduce side effects while increasing efficacy and improving survival rates. If you're receiving targeted therapy for your lung cancer, this means that your doctor has found targets on the surface of cancer cells or in your tumor.

Generally, targeted and immunotherapies can include one of the following forms:

• Small molecules: These can enter cells effortlessly, so they are utilized for intracellular targeting.
• Monoclonal antibodies: These are proteins synthesized in the lab with varying techniques. Some are made to mark cancer cells to be recognized by the immune system and destroyed, others can stop cancer cells from growing or cause them to self-destruct, and then some are loaded with toxic drugs to directly project them into cancer cells. This last form is called an antibody drug conjugate and there have been many new exciting advancements with this type f therapy.

Putting Out Good Vibes & Lundgren’s Sense of Karma

"I've always tried to be nice to everybody and meet fans, anybody, and it maybe came back to me somehow now when I needed it the most," he told The LA Times. "I think when you put love out there, you get it back."

 

 

 

Learn more about SurvivorNet's rigorous medical review process.